Back
BioCryst Pharmaceuticals, Inc. Stock Predictions
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
31
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$6.80
Seasonality Move:
-4.33%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assetsBioCryst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 56.6% based on the past 31 years of stock performance.
-
BioCryst Pharmaceuticals, Inc. has risen higher in 12 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.71%
-
Is BioCryst Pharmaceuticals, Inc. Stock Undervalued?The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $6.75. The Score for BCRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 56.6% based on the past 31 years of stock performance.
BioCryst Pharmaceuticals, Inc. Stock Rating
Sell
31
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Sell
Is BioCryst Pharmaceuticals, Inc. overpriced?
-
BioCryst Pharmaceuticals, Inc. has risen higher in 12 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.71%
BioCryst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
11.31
52-Week Low:
6.00
Prediction Charts
Market Cap:
1.4B
Price in USD:
6.75
Volume:
6.7M
Beta:
1.66
Technical Analysis
SMA50:
7.30
SMA100:
7.37
SMA200:
8.22
52-Wk Change:
-11.42%
Stock Predictions
-
Is BioCryst Pharmaceuticals, Inc. stock public?Yes, BioCryst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the BioCryst Pharmaceuticals, Inc. stock quote today?The BioCryst Pharmaceuticals, Inc. stock price is 6.75 USD today.
-
How to buy BioCryst Pharmaceuticals, Inc. stock online?You can buy BioCryst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 7.82 | 7.50 | 7.90 | 7.46 |
| Jan-5 | 7.41 | 7.41 | 7.53 | 7.21 |
| Jan-6 | 7.38 | 7.58 | 7.63 | 7.36 |
| Jan-7 | 7.59 | 7.92 | 8.05 | 7.56 |
| Jan-8 | 7.85 | 7.62 | 7.91 | 7.52 |
| Jan-9 | 7.65 | 7.40 | 8.04 | 7.38 |
| Jan-12 | 7.30 | 7.09 | 7.33 | 6.99 |
| Jan-13 | 7.13 | 6.75 | 7.13 | 6.69 |
| Jan-14 | 6.72 | 6.78 | 6.85 | 6.69 |
| Jan-15 | 6.79 | 7.17 | 7.27 | 6.64 |
| Jan-16 | 7.12 | 6.66 | 7.17 | 6.58 |
| Jan-20 | 6.50 | 6.67 | 6.70 | 6.46 |
| Jan-21 | 6.66 | 6.72 | 6.74 | 6.60 |
| Jan-22 | 6.69 | 6.75 | 6.87 | 6.63 |
BioCryst Pharmaceuticals, Inc. Earnings
BioCryst Pharmaceuticals, Inc. Earnings Report: Per Share BioCryst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals, Inc. Forecast Revenue Growth
BioCryst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.23 per share.
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.